The smirking, villainous pharma-hedge-douche-bro Martin Shkreli (previously) bought the rights to the anti-parasitic drug Daraprim -- used to treat malaria, a disease that disproportionately affects the poorest people in the world -- and jacked the price from $13.50/dose to $750/dose. (more…)